Day: December 16, 2025

Collaboration integrates firewalling, segmentation, and policy enforcement directly into NVIDIA BlueField-accelerated infrastructure for higher performance, stronger isolation, and simpler operations SUNNYVALE, Calif. and SANTA CLARA, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) — Fortinet® (NASDAQ: FTNT), the global cybersecurity leader driving the convergence of networking and security, today announced an integrated solution featuring FortiGate VM, Fortinet’s virtual cloud firewall, running directly on the NVIDIA BlueField-3 data processing unit (DPU). This integration embeds networking and brings isolated infrastructure acceleration into the AI Factory, allowing core security functions to run on BlueField instead of the host. By moving protection into the data center infrastructure itself, the solution helps enterprises secure high-performance...

Integrated marketing services provider introduces parent- and kid-friendly ad platform, powered by BrightStream and Wild Sky Media  Boca Raton, FL, Dec. 16, 2025 (GLOBE NEWSWIRE) — Bright Mountain Media, (OTCQB: BMTM) (“Bright Mountain” or the “Company”), a marketing services platform company that empowers brands, agencies and publishers to go further, faster, today announced the launch of familyroom, a proprietary, family-focused advertising solution built in partnership with Wild Sky Media, the parent company of Mom.com, CafeMom, MamasLatinas, and LittleThings. By combining efforts from its companies, including consumer insights and analytics firm, Big Village; BrightStream, its leading programmatic supply-side platform (SSP), and Wild Sky Media, the parent company of Mom.com, CafeMom, MamasLatinas, and LittleThings, Bright Mountain...

BROSSARD, Quebec, Dec. 16, 2025 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in applying techniques in Artificial Intelligence (AI) for the early detection of eye-related health issues, is pleased to announce the appointment of Dr. Ismail Ben Ayed, as Chief Artificial Intelligence (AI) Scientist. Mr. Ben Ayed is an expert in medical image analysis algorithms, machine learning and computer vision. Mr. Ben Ayed will guide the Company’s strategic direction in AI research and development. His mandate includes advancing the accuracy, efficiency, and clinical utility of DIAGNOS’ proprietary CARA (Computer-Assisted Retinal Analysis) System platform and expanding AI capabilities to support detection of eye related diseases. A recognized leader in AI for Medical...

A redesigned Weight Watchers experience pairs GLP-1 prescriptions with personalized nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and achieve results that lastWeight Watchers launches a fully integrated platform for the GLP-1 eraWeight Watchers introduces a new, fully integrated experience that unites GLP-1 prescribing, personalized nutrition, behavioral support, coaching, and community within a redesigned app experience and digital platformNEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) — WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight management, today introduced a new, fully integrated experience that unites GLP-1 prescribing, personalized nutrition, behavioral support, coaching, and community within a redesigned...

Accelerates its growth in aviation energy solutions with significant new orders, deepening its presence among leading North American airlines VISTA, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) — Flux Power Holdings, Inc. (NASDAQ: FLUX), a leading developer of advanced lithium-ion energy storage solutions and software-driven electrification for commercial and industrial equipment, announced today that it has secured more than $3.6 million in additional purchase orders to support a long-standing airline customer. Ranked among the top ten North American airlines, this marks another significant milestone for the company’s leadership and its continued growth in the aviation sector. The renewed commitment from a recurring customer reflects proven performance and reliability, reinforcing the company’s role as a trusted partner for mission-critical...

Vivos Eyes High Growth Potential from Commercial Affiliation with Prominent Auburn Hills, Michigan Sleep Practice MISleep Solutions LITTLETON, Colo., Dec. 16, 2025 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and healthcare services company focused on sleep related breathing disorders, including obstructive sleep apnea (OSA), is pleased to announce the grand opening of its latest sleep testing and treatment center near Detroit in Auburn Hills, Michigan. This new center represents an extension of Vivos’ sleep center affiliation model—a capital-efficient and scalable version of Vivos’ growing operations in Las Vegas, Nevada. This model can take the form of contractual alliances, such as in Auburn Hills, or outright acquisitions of sleep medical practices, such as...

Vancouver, Canada, Dec. 16, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on the discovery and development of novel neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced the successful completion of patient enrollment for the second cohort in its ongoing FDA-approved Phase I/IIa clinical trial evaluating CMND-100, the Company’s proprietary MEAI-based oral drug candidate, for the treatment of Alcohol Use Disorder (AUD). The cohort consists of six patients, who were recruited rapidly across three premier clinical sites: Johns Hopkins University, Tel Aviv Sourasky Medical Center, and Hadassah Medical Center. This milestone follows the recent completion of the first cohort, which...

Regulatory submission marks a significant milestone as the Company advances toward Phase 2/3 trial initiation in Q2 2026 at full speed Application follows recent successful toxicology studies, positive German regulatory feedback, and strong preclinical data demonstrating up to 99.7% cancer cell inhibition Regulatory filings in Germany and the EU are planned for Q1 2026, with U.S. expansion anticipated following the safety run-in Grand Cayman, Cayman Islands, Dec. 16, 2025 (GLOBE NEWSWIRE) — Silexion Therapeutics, a clinical-stage biotechnology company advancing RNA-based therapies for oncology, today announced the initiation of its regulatory application in Israel for its planned Phase 2/3 clinical trial of SIL204 in patients with locally advanced pancreatic cancer (LAPC), based on the positive Scientific Advice response received...

LAS VEGAS, Dec. 16, 2025 (GLOBE NEWSWIRE) — Starstream Entertainment Inc. (OTCID:SSET) today announced a change of control and the introduction of a renewed strategic focus designed to strengthen the company’s operational foundation and drive long-term shareholder value. As part of this transition, Mr. Zhong Lin has been appointed as a director of the company and will participate in guiding Starstream’s oversight, governance, and future strategic direction. The Board is actively evaluating initiatives to enhance operational discipline and assess new commercial opportunities aligned with sustainable growth. “We are committed to building a strong foundation for Starstream’s next phase,” said Mr. Zhong Lin, Director of Starstream Entertainment Inc. “Our focus is on responsible governance, transparency, and identifying business opportunities...

Not for distribution to U.S. News Wire Services or dissemination in the United States. BRAMPTON, Ontario, Dec. 16, 2025 (GLOBE NEWSWIRE) — Loblaw Companies Limited (“Loblaw” or the “Company”) announced today that it has completed its previously announced issuance (the “Offering”), on a private placement basis to qualified accredited investors in certain Provinces of Canada, of $500 million aggregate principal amount of senior unsecured notes of the Company (the “Notes”). The Notes bear interest at a rate of 4.387% per annum and mature on June 16, 2035. The Company intends to use the net proceeds of the Offering to repay outstanding indebtedness under the Company’s syndicated revolving credit facility and for general corporate purposes. The Notes are unsecured obligations of the Company and rank equally with all existing and future...